Kurt Von Emster Cyma Bay Therapeutics, Inc. (CBAY) insider trading activity

CBAY Quotes by TradingView

Kurt Von Emster is of CymaBay Therapeutics, Inc.. Currently has a direct ownership of 0 shares of CBAY, which is worth approximately $0. The most recent transaction as insider was on Mar 22, 2024, when has been sold 90,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

KURT VON EMSTER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 22 2024
SELL
Sale (or disposition) back to the issuer
-
90,000 Reduced 100.0%
0 Common Stock
Sep 29 2023
SELL
Open market or private sale
$249,641 $15.68 p/Share
15,921 Reduced 15.03%
90,000 Common Stock
Sep 29 2023
BUY
Exercise of conversion of derivative security
$79,605 $5.0 p/Share
15,921 Added 13.07%
105,921 Common Stock

Also insider at

CRSP
CRISPR Therapeutics AG Healthcare
Director
PCVX
Vaxcyte, Inc. Healthcare
Director
VERA
Vera Therapeutics, Inc. Healthcare
Director
JSPR
Jasper Therapeutics, Inc. Healthcare
Director
KVE

Kurt Von Emster

Foster City, CA

Track Institutional and Insider Activities on CBAY

Follow CymaBay Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CBAY shares.

Notify only if

Insider Trading

Get notified when an Cyma Bay Therapeutics, Inc. insider buys or sells CBAY shares.

Notify only if

News

Receive news related to CymaBay Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CBAY